Institutional investors purchased a net $4.1 million shares of CYTR during the quarter ended June 2017, and now own 8.57% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 1.7 Million shares of CytRx Corp
MILLENNIUM MANAGEMENT LLC Bought 689.3 Thousand shares of CytRx Corp